During the past decade, Lovelace Medical Center-Saint Joseph Square conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 19 clinical trials were completed, i.e. on average, 47.5% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 14 clinical trials were completed. i.e. 140% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lovelace Medical Center-Saint Joseph Square" #1 sponsor was "National Cancer Institute (NCI)" with 27 trials, followed by "SWOG Cancer Research Network" with 12 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "NRG Oncology" with 4 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lovelace Medical Center-Saint Joseph Square" #1 collaborator was "National Cancer Institute (NCI)" with 24 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Bayer" with 2 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "Eastern Cooperative Oncology Group" with 2 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Lovelace Medical Center-Saint Joseph Square" are "Invasive Breast Carcinoma" (4 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (4 trials), "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (4 trials), "Recurrent Squamous Cell Lung Carcinoma" (3 trials) and "Stage II Lung Non-Small Cell Cancer AJCC v7" (3 trials). Many other conditions were trialed in "Lovelace Medical Center-Saint Joseph Square" in a lesser frequency.

Most popular intervention types in "Lovelace Medical Center-Saint Joseph Square" are "Drug" (41 trials), "Other" (34 trials), "Biological" (24 trials), "Procedure" (13 trials) and "Radiation" (9 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (21 trials), "Quality-of-Life Assessment" (13 trials), "Nivolumab" (11 trials), "Biospecimen Collection" (9 trials) and "Cisplatin" (9 trials). Other intervention names were less common.

The vast majority of trials in "Lovelace Medical Center-Saint Joseph Square" are 47 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Lovelace Medical Center-Saint Joseph Square". undefined are not yet recruiting, 13 are recruiting, 32 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Lovelace Medical Center-Saint Joseph Square, 2 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Lovelace Medical Center-Saint Joseph Square, 0 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".